Matt Gamber’s Biotech Newsletter
by Matt GamberMatt Gamber’s Biotech Newsletter
About the Substack
Weekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.
Free Subscription Benefits
- One free monthly post on performance
Paid Subcription Benefits
- One weekly paid post averaging 2,750+ words and multimedia
- Occasional bonus posts when major breaking news happens in my coverage spectrum
- Subscriber chat and e-mail access
Paid Subscription Plans
- $100 a year
- $10 a month
About Matt Gamber
Subscriber Growth
The number of free subscribers for Matt Gamber’s Biotech Newsletter over time since it was added to the directory.
Is this your Substack?
Submit changes.